Welcome to our dedicated page for Knowles SEC filings (Ticker: KN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating how Knowles allocates R&D between its MEMS microphones and high-performance capacitors isn’t easy—each report weaves in dense technical tables. If you’ve searched "Knowles SEC filings explained simply" or asked "What does Knowles report in their SEC filings?", you’re not alone. Stock Titan brings clarity to these intricate disclosures so you can see, in plain language, how shifts in mobile, medtech & specialty audio revenue affect future cash flow.
Our real-time dashboard streams every document the moment it reaches EDGAR—from a Knowles quarterly earnings report 10-Q filing that breaks out Consumer MEMS margins to a Knowles 8-K material events explained alert when manufacturing moves. Want insider activity? Knowles insider trading Form 4 transactions and Knowles Form 4 insider transactions real-time are automatically summarized, including Knowles executive stock transactions Form 4 patterns that precede product launches. You’ll also find the Knowles annual report 10-K simplified with AI-generated overviews, plus easy links to the latest Knowles proxy statement executive compensation details and Knowles earnings report filing analysis for trend comparisons.
Behind the scenes, our AI reads every footnote so you don’t have to. Understanding Knowles SEC documents with AI means spotting changes in segment disclosure, warranty reserves or patent litigation in seconds. Investors use these insights to monitor supply-chain risk, compare quarter-over-quarter component demand, and benchmark pricing power against peers. Save hours, gain confidence, and make informed decisions—all from one SEC filings hub built for Knowles Corporation.
Knowles Corporation (KN)11/21/2025, the executive sold a total of 30,000 shares of Knowles common stock in three separate open-market transactions. The reported weighted average sale prices were $20.90, $20.80, and $21.50 per share.
The filing notes that for the two weighted-average prices, the shares were sold in multiple trades within price ranges of $20.67–$21.055 and $20.75–$20.89, and detailed breakdowns are available upon request. After these sales, the executive directly holds 217,299 shares of Knowles common stock.
A holder of KN common stock filed a Form 144 notice to sell up to 30,000 shares through Morgan Stanley Smith Barney LLC on the NYSE. The planned sale has an stated aggregate market value of $631,941.00. The filing notes that 85,151,884 shares of the same class of common stock are outstanding, giving a sense of the sale’s relative size. The approximate sale date disclosed is 11/21/2025. The shares to be sold were acquired from the issuer through a mix of exercised shares, restricted stock, and performance shares granted between 2021 and 2024.
Ariel Investments, LLC filed Amendment No. 4 to Schedule 13G reporting beneficial ownership in Knowles Corp (KN). Ariel reports 4,108,160 shares beneficially owned, representing 4.8% of the common stock, as of the event date 09/30/2025.
The firm has sole voting power over 3,752,222 shares and sole dispositive power over 4,108,160 shares, with no shared voting or dispositive power. Ariel states the holdings were acquired and are held in the ordinary course of business and not to change or influence control. Ariel’s adviser clients have the right to receive dividends or sale proceeds; none hold more than 5%.
Knowles (KN) President & CEO and Director Jeffrey Niew reported option exercises and open-market sales. He exercised non-qualified stock options at $16.07 for 98,252 shares on 10/31/2025 and 38,404 shares on 11/03/2025, then sold the same amounts at weighted average prices of $23.7148 and $23.5498, respectively. Following these transactions, he directly owned 939,370 shares.
The option entries list grant terms with a date exercisable of 02/19/2020 and an expiration date of 02/19/2026. The footnotes state the sales were executed in multiple trades within price ranges of $23.70–$23.81 and $23.40–$23.68, with full trade details available upon request.
Franklin Mutual Advisers, LLC filed a Schedule 13G disclosing a passive beneficial ownership in Knowles Corporation (KN). The firm reported 4,557,663 shares of Knowles common stock, representing 5.3% of the class as of 09/30/2025.
Franklin Mutual Advisers reported sole voting power over 4,300,173 shares and sole dispositive power over 4,557,663 shares, with no shared voting or dispositive power. The filing states the securities are held in the ordinary course and not to change or influence control. The position is held on behalf of the firm’s investment management clients, who have rights to dividends and sale proceeds.
Knowles (KN) filed a Form 144 notice for a proposed sale of 38,404 shares of common stock, with an aggregate market value of $904,402.68. The shares were acquired via a stock option exercise on the same date listed for sale and paid in cash. The filing lists Morgan Stanley Smith Barney LLC as broker and identifies the NYSE as the exchange, with an approximate sale date of 11/03/2025. As context, 85,151,884 shares were outstanding. The notice also reports a recent sale by the same individual of 98,252 shares on 10/31/2025 for $2,330,026.53 in gross proceeds.
Knowles (KN) had a Form 144 notice filed for a proposed sale of up to 98,252 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, reflecting an approximate aggregate market value of $2,330,026.53. The filer lists an approximate sale date of October 31, 2025.
The shares were acquired on October 31, 2025 via a stock option exercise from the issuer, paid in cash. The filing also lists 85,151,884 shares outstanding. Form 144 is a notice of intent to sell restricted or control securities under Rule 144; any actual sales would follow the rule’s conditions.
Knowles Corporation (KN) reported stronger quarterly results. For the three months ended September 30, 2025, revenue was $152.9 million, up from $142.5 million, driven by higher demand in Precision Devices and steady MedTech & Specialty Audio activity. Operating earnings rose to $25.8 million from $18.7 million as gross profit improved to $69.9 million.
Earnings from continuing operations were $18.0 million, or $0.21 per diluted share, versus $0.10 a year ago, helped by lower interest expense. Discontinued operations related to the 2024 sale of Consumer MEMS Microphones contributed a $0.6 million loss. Year to date, revenue reached $431.0 million and operating earnings were $44.5 million.
Cash from operating activities was $66.8 million for the nine months. Cash stood at $92.5 million with total debt of $176.3 million, including a $72.7 million Seller Note due in Q4 2025 and $104.0 million drawn on the revolving credit facility due 2028. The company repurchased 3.12 million shares for $55.0 million year to date, with $139.0 million remaining under authorization. Shares outstanding were 85,151,884 as of October 24, 2025.
Knowles Corporation filed an 8-K under Item 2.02 stating it has announced results for the quarter ended September 30, 2025. The company furnished a press release and presentation slides as Exhibits 99.1 and 99.2, and held its quarterly conference call and webcast on October 23, 2025. The materials are furnished, not filed, and therefore are not incorporated into Securities Act filings unless specifically referenced. The filing includes forward-looking statements language, noting estimates related to the expected impact, timing, and amounts of restructuring charges.
Knowles Corp (KN) insider Raymond D. Cabrera exercised non-qualified stock options on 08/25/2025, converting 24,116 options with an exercise price of $16.07 into 24,116 shares. The filing shows 20,795 shares were withheld/sold at $21.35 to cover the option exercise price and tax obligations. After the transactions the filing reports 114,607 shares beneficially owned by Mr. Cabrera (down from 135,402 prior to the disposition). The option exercised was originally granted 02/19/2020 and expires 02/19/2026. The form is signed by a POA on behalf of the reporting person.